Similarly, transcriptional analysis has proved that some tumors are able to acquire resistance to specific OVs by increasing IFN levels in the TME [131], and high-throughput screening of chemical libraries has been successful in identifying drugs that can neutralize these pathways and restore tumor sensitivity to OVs [132]. Here, IFNA1 is linked to neoplasm.